NNelo Trade
← Back to Market News
November 16, 2026 at 12:07 PM UTC

InMed Pharmaceuticals Inc. reports acquisition or asset disposition

InMed Pharmaceuticals Inc. filed an 8-K covering an acquisition or disposition of assets and results of operations or financial condition. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: November 16, 2026 at 12:03 PM UTC

Open official source
InMed Pharmaceuticals Inc. reports acquisition or asset disposition | Nelo Trade